Oral Contraceptives Abolish Luteal Phase Exacerbation of Hyperglycemia in Type I Diabetes
The DOI matches its Crossref record.
Abstract
For some time it has been recognized that postovulatory exacerbation of hyperglycemia contributes to the instability of diabetes in many women of reproductive age. It has been suggested that increasing plasma levels of progesterone and estrogen may induce insulin resistance and consequently lead to increased hyperglycemia during the luteal phase of the menstrual cycle. Due to the fact that menstrual cycles in a given woman may vary in length and that it takes patients several days on intermediate or long-acting insulin to achieve a steady state with regard to any dosage adjustment, it is difficult to design an insulin regimen that maintains euglycemia throughout the menstrual cycle in these labile patients. Recognition of this problem led to trying a nonsequential low estrogen contraceptive as adjunctive therapy in a 20-year old woman with insulin dependent diabetes mellitus. The patient consistently suffered an exacerbation of hyperglycemia after ovulation in each cycle, lasting until the onset of menses. On 1 occasion the patient developed frank diabetic ketoacidosis. For the first 2 cycles on Lo Ovral, the hyperglycemia was postponed from the 1st postovulatory day until day 18-19 of the cycle. It was reasoned that the serum estrogen and/or progestin level might be building cumulatively, and the oral contraceptives (OCs) were subsequently withdrawn at day 19 of the cycle rather than day 21. A maximum blood glucose level of 400 mg/dl was attained at day 19 and was treated with additional regular insulin. Levels in excess of 240 mg/dl did not recur during that cycle. The following cycle OC therapy was interrupted at day 18; no blood glucose level in excess of 240 mg/dl occurred that month. Hemoglobin A1c fell from a pre-OC treatment value of 12.4% to the current A1c of 9.7%. A modest increase in blood pressure has occurred, but this is easily managed with a 2 g sodium diet and 25 mg of hydrochlorothiazide daily. On the basis of this experience, a controlled trial is warranted of low dose estrogen nonsequential OCs in lean, nonsmoking, 18-30 year old women with insulin dependent diabetes mellitus with postovulatory hyperglycemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Female reproduction and type 1 diabetes: From mechanisms to clinical findings
Codner, E., Merino, P. M., & Tena-Sempere, M. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms024 · Cited by 182
“These catamenial reactions were treated with GnRH analogues, increased insulin, or low doses of combined oral contraceptives (Sacerdote and Bleicher, 1982; Letterie and Fredlund, 1994; Sennik et al., 2010).”
BackgroundMenstrual cyclicity has a profound effect on glucose homeostasis.
Diamond, M. P., Simonson, D. C., & DeFronzo, R. A. (1989) · Fertility and Sterility · doi:10.1016/s0015-0282(16)60842-7 · Cited by 98
Goldner, W. S., Kraus, V. L., Sivitz, W. I., Hunter, S. K., & Dillon, J. S. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/1520915041705875 · Cited by 55
Diaz C., J. L., Fabris, C., Breton, M. D., & Cengiz, E. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0154 · Cited by 19
“16 A substantial body of evidence suggests that LP is linked to increased exposure to hyperglycemia compared with FP. 5,6,13–15 Furthermore, IS assessed through hyperglycemic–hyperinsulinemic clamps 17 or intravenous glucose tolerance tests 18 was reported to decrease in LP compared with FP.…”
Lundman, B., Asplund, K., & Norberg, A. (1994) · International Journal of Nursing Studies · doi:10.1016/0020-7489(94)90079-5 · Cited by 9
Metadata
- Authors
- Sacerdote, A., & Bleicher, S. J.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1982-11-01
- Volume
- 5
- Issue
- 6
- Pages
- 651-652
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2094517868
- Cited by
- 11
- References
- 0
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oral Contraceptives Abolish Luteal Phase Exacerbation of Hyperglycemia in Type I Diabetes. https://app.cochat.ai/papers/10.2337/diacare.5.6.651b
- The paper
- Sacerdote, A., & Bleicher, S. J. (1982). Oral Contraceptives Abolish Luteal Phase Exacerbation of Hyperglycemia in Type I Diabetes. Diabetes Care. https://doi.org/10.2337/diacare.5.6.651b
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.